Adriana Garduño-Alanis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adriana Garduño-Alanis has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Gabriela Torres-Mejía
Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México...
12 shared publications - Angélica Ángeles-Llerenas
Instituto Nacional de Salud Pública 2 Centro de Investigación en Salud Poblacional Cuernavaca, Mexico
11 shared publications - Lourdes Flores-Luna
Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Mexico
11 shared publications - Luisa María Sánchez-Zamorano
Instituto Nacional De Salud Pública: Programa De Doctorado En Ciencias De Enfermedades Infecciosas
11 shared publications - Mario Flores
Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Mexico
11 shared publications - Hugo Mendieta Zerón
Facultad de Medicina, Universidad Autónoma del Estado de México (UAEMéx), Toluca de Lerdo, Mexico
3 shared publications
Latest Publications
- 20 March 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 399, 119209
Changes in sales of packaged food and beverages, energy, and nutrients after the implementation of front-of-pack warning labels in Mexico
- 20 March 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 399, 119209
Changes in sales of packaged food and beverages, energy, and nutrients after the implementation of front-of-pack warning labels in Mexico
- Open Access
- 4 July 2024
- Published by Dirección de Bienes Públicos del Conocimiento, Universidad Autonoma del Estado de Mexico in Medicina e Investigación Universidad Autónoma del Estado de México
- Vol. 12 (2) , 97-108
Estrategias nutricionales para la disminución de Long COVID-19. Una Revisión de la literatura
Introducción: La pandemia por la COVID-19, se originó por el virus SARS-CoV-2, afectando a más personas con comorbilidades preexistentes, baja actividad física y estilos de vida no saludables. Se conoce que antes de la pandemia, la alimentación de las personas era deficiente, por lo que existe una gran necesidad de seguir estrategias nutricionales para la prevención de infecciones por Long COVID-19. Objetivo: Identificar las estrategias nutricionales para la disminución de Long COVID. Material y métodos: Se hizo una búsqueda exhaustiva de fuentes de datos electrónicos en PubMed, Web of Science, RedAlyC, Google Scholar, Biblioteca Cochrane, y Scopus, publicados en el periodo de 2020- 2023, utilizando términos MeSH “nutrición” “estrategias nutricionales” “COVID-19”, “pautas nutricionales y “recomendaciones nutricionales” No se aplicaron restricciones de idioma siguiendo las directrices en la norma PRISMA. Resultados: Se seleccionaron 19 estudios publicados en el periodo 2020 y 2023, de tipo cohorte, ensayo clínico, transversal y prospectivo. Al analizar la información, se identificó tres temas relacionados con el efecto de la nutrición y Long COVID: i) adherencia a la dieta mediterránea, ii) calidad de dieta y iii) intervención nutricional con suplementación de componentes no energéticos. La dieta mediterránea fue la terapia nutricional más recomendada debido a la calidad de alimentos y los beneficios en la enfermedad cardiovascular, sensibilidad a la insulina y perfil de lípidos, y disminución de la inflamación, siendo el sexo femenino reporta mayor adherencia del 77% teniendo como resultado niveles más bajos de triglicéridos, IMC, perímetro abdominal y citocinas proinflamatorias. Conclusiones: Una nutrición adecuada para todas las células del sistema inmunológico tendrá una función homeostáticamente, esto a través del seguimiento y cumplimiento de estrategias que propicien un estilo de vida saludable.
- 4 July 2024
- Published by Dirección de Bienes Públicos del Conocimiento, Universidad Autonoma del Estado de Mexico in Medicina e Investigación Universidad Autónoma del Estado de México
- Vol. 12 (2) , 97-108
Open AccessEstrategias nutricionales para la disminución de Long COVID-19. Una Revisión de la literatura
Introducción: La pandemia por la COVID-19, se originó por el virus SARS-CoV-2, afectando a más personas con comorbilidades preexistentes, baja actividad física y estilos de vida no saludables. Se conoce que antes de la pandemia, la alimentación de las personas era deficiente, por lo que existe una gran necesidad de seguir estrategias nutricionales para la prevención de infecciones por Long COVID-19. Objetivo: Identificar las estrategias nutricionales para la disminución de Long COVID. Material y métodos: Se hizo una búsqueda exhaustiva de fuentes de datos electrónicos en PubMed, Web of Science, RedAlyC, Google Scholar, Biblioteca Cochrane, y Scopus, publicados en el periodo de 2020- 2023, utilizando términos MeSH “nutrición” “estrategias nutricionales” “COVID-19”, “pautas nutricionales y “recomendaciones nutricionales” No se aplicaron restricciones de idioma siguiendo las directrices en la norma PRISMA. Resultados: Se seleccionaron 19 estudios publicados en el periodo 2020 y 2023, de tipo cohorte, ensayo clínico, transversal y prospectivo. Al analizar la información, se identificó tres temas relacionados con el efecto de la nutrición y Long COVID: i) adherencia a la dieta mediterránea, ii) calidad de dieta y iii) intervención nutricional con suplementación de componentes no energéticos. La dieta mediterránea fue la terapia nutricional más recomendada debido a la calidad de alimentos y los beneficios en la enfermedad cardiovascular, sensibilidad a la insulina y perfil de lípidos, y disminución de la inflamación, siendo el sexo femenino reporta mayor adherencia del 77% teniendo como resultado niveles más bajos de triglicéridos, IMC, perímetro abdominal y citocinas proinflamatorias. Conclusiones: Una nutrición adecuada para todas las células del sistema inmunológico tendrá una función homeostáticamente, esto a través del seguimiento y cumplimiento de estrategias que propicien un estilo de vida saludable.
- Open Access
- 10 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0301387
A high density of ultra-processed food, alcohol & tobacco retail stores, and social inequalities are associated with higher mortality rates of non-communicable diseases in Mexican adults: 2005 to 2021
Background: Non-communicable diseases (NCDs) are the leading causes of mortality in Mexico. Factors contributing to NCDs-related deaths may vary across small geographic areas such as municipalities. We aimed to predict municipal-level factors associated with NCD mortality in Mexican adults from 2005 to 2021 using the small-area analysis (SSA) approach. Methods: We gathered data on population sociodemographic, access to healthcare services, and mortality records at the municipal-level from census and public institutions from 2005 to 2021. We identified municipal predictors of NCDs mortality rates (MR) using negative binomial regression models. Results: A total of 584,052 observations of Mexican adults were analyzed. The national expected NCDs MR per 100,000 inhabitants was 210.7 (95%CI: 196.1–226.7) in 2005 and increased to 322.4 (95%CI: 300.3–346.4) by 2021. Predictors of NCDs mortality (quintile 5 vs. quintile 1) included; indigeneity (IRR = 1.15, 95%CI: 1.12–1.19), poverty (IRR = 1.14, 95%CI: 1.13–1.15), affiliation with Mexican Social Security Institute (IRR = 1.11, 95%CI: 1.09–1.14), households with television (IRR = 1.14, 95%CI: 1.11–1.17), and high density of ultra-processed food, alcohol & tobacco retail stores (IRR = 1.15, 95%CI: 1.13–1.17). The greatest increases in MR were observed in municipalities from Oaxaca (>200% increments). Conclusion: There was an overall increase in NCDs MR from 2005 to 2021, with a significant geographic variation among Mexican municipalities. The results of this study highlight the importance of identifying priority areas in the country that urgently require public policies focused on local factors associated with deaths from NCDs, such as the regulation of the ultra-processed food, alcohol & tobacco retail stores, and efforts to reduce social inequalities.
- 10 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0301387
Open AccessA high density of ultra-processed food, alcohol & tobacco retail stores, and social inequalities are associated with higher mortality rates of non-communicable diseases in Mexican adults: 2005 to 2021
Background: Non-communicable diseases (NCDs) are the leading causes of mortality in Mexico. Factors contributing to NCDs-related deaths may vary across small geographic areas such as municipalities. We aimed to predict municipal-level factors associated with NCD mortality in Mexican adults from 2005 to 2021 using the small-area analysis (SSA) approach. Methods: We gathered data on population sociodemographic, access to healthcare services, and mortality records at the municipal-level from census and public institutions from 2005 to 2021. We identified municipal predictors of NCDs mortality rates (MR) using negative binomial regression models. Results: A total of 584,052 observations of Mexican adults were analyzed. The national expected NCDs MR per 100,000 inhabitants was 210.7 (95%CI: 196.1–226.7) in 2005 and increased to 322.4 (95%CI: 300.3–346.4) by 2021. Predictors of NCDs mortality (quintile 5 vs. quintile 1) included; indigeneity (IRR = 1.15, 95%CI: 1.12–1.19), poverty (IRR = 1.14, 95%CI: 1.13–1.15), affiliation with Mexican Social Security Institute (IRR = 1.11, 95%CI: 1.09–1.14), households with television (IRR = 1.14, 95%CI: 1.11–1.17), and high density of ultra-processed food, alcohol & tobacco retail stores (IRR = 1.15, 95%CI: 1.13–1.17). The greatest increases in MR were observed in municipalities from Oaxaca (>200% increments). Conclusion: There was an overall increase in NCDs MR from 2005 to 2021, with a significant geographic variation among Mexican municipalities. The results of this study highlight the importance of identifying priority areas in the country that urgently require public policies focused on local factors associated with deaths from NCDs, such as the regulation of the ultra-processed food, alcohol & tobacco retail stores, and efforts to reduce social inequalities.
- Open Access
- 29 February 2024
- Published by Andijan State Medical Institute in Международный журнал научной педиатрии
- Vol. 3 (2) , 479-484
CYCLIN B1 EXPRESSION IN MOTHERS OF DOWN SYNDROME VERSUS EUPLOID CHILDREN
Introduction. Down Syndrome (DS) is the most common chromosomopathy. Cyclin B1 is a regulatory protein involved in mitosis. The aim was to determine the cyclin B1 relative expression in mothers of DS patients. Methods. In this cross-sectional study, mononuclear cells of peripheral blood were obtained from 40 mothers of confirmed DS patients and 40 mothers of euploid patients, between 2019-2021. Demographic variables and cyclin B1 messenger RNA (mRNA) with real-time polymerase chain reaction (qPCR) were analyzed. The cases of DS mothers were compared to the relative expression of euploid group. Results. cyclin B1 mean relative expression by RT-PCR showed a significant difference between the group of mothers of DS children and mothers of euploid children (p < 0.05). The expression of the cyclin B1 was lower than the mean of mothers with euploid patients. Previously, it has been reported that the cyclin B1 down expression should accelerate telomere shortening in DS patients. Therefore, it would be advisable to recategorize the maternal age-related risk factor. Conclusion. Cyclin B1 may be a cost-effective biomarker in reproductive age women to present a DS case not associated with chronological age.
- 29 February 2024
- Published by Andijan State Medical Institute in Международный журнал научной педиатрии
- Vol. 3 (2) , 479-484
Open AccessCYCLIN B1 EXPRESSION IN MOTHERS OF DOWN SYNDROME VERSUS EUPLOID CHILDREN
Introduction. Down Syndrome (DS) is the most common chromosomopathy. Cyclin B1 is a regulatory protein involved in mitosis. The aim was to determine the cyclin B1 relative expression in mothers of DS patients. Methods. In this cross-sectional study, mononuclear cells of peripheral blood were obtained from 40 mothers of confirmed DS patients and 40 mothers of euploid patients, between 2019-2021. Demographic variables and cyclin B1 messenger RNA (mRNA) with real-time polymerase chain reaction (qPCR) were analyzed. The cases of DS mothers were compared to the relative expression of euploid group. Results. cyclin B1 mean relative expression by RT-PCR showed a significant difference between the group of mothers of DS children and mothers of euploid children (p < 0.05). The expression of the cyclin B1 was lower than the mean of mothers with euploid patients. Previously, it has been reported that the cyclin B1 down expression should accelerate telomere shortening in DS patients. Therefore, it would be advisable to recategorize the maternal age-related risk factor. Conclusion. Cyclin B1 may be a cost-effective biomarker in reproductive age women to present a DS case not associated with chronological age.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S4 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for healthy dietary index in Postmenopausal women.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S4 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for healthy dietary index in Postmenopausal women.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S1 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Premenopausal women.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S1 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Premenopausal women.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S4 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for healthy dietary index in Postmenopausal women.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S4 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for healthy dietary index in Postmenopausal women.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S1 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Premenopausal women.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S1 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Premenopausal women.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S3 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Postmenopausalwomen.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Supplementary Table S3 shows Sugar-sweetened beverages consumption and the risk of breast cancer model adjusted for kilocalories in Postmenopausalwomen.
- Open Access
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Data from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Background:The consumption of sugar-sweetened beverages (SSB), of which Mexico is a large consumer, has been associated with the risk of breast cancer. We assessed the association between SSBs consumption and breast cancer risk in pre- and postmenopausal women.Methods:We performed a multicenter population-based case–control study in Mexico City, Monterrey, and Veracruz. We recruited 1,000 cases and 1,074 controls; all participants were pre- or postmenopausal women between 35 and 69 years of age. Diet before symptoms onset was assessed using a food frequency questionnaire. We conducted a multivariable-adjusted conditional logistic regression analysis stratified by menopausal status.Results:For premenopausal women, after adjusting for matching characteristics, total energy intake and all potential confounders, the odds of having breast cancer in women who drank one or more SSBs servings per day showed 1.78 times the odds of those who drank one or fewer SSBs servings per month [OR = 1.78; 95% confidence interval (CI), 1.06–3.01]. For postmenopausal women, the corresponding model was not statistically significant (OR = 1.38, 95% CI, 0.84–2.25). We also observed higher consumption of SSBs among pre- than in postmenopausal women (23.3% and 17.4%, respectively among controls in the highest consumption category (≥1 per day).Conclusions:Our results suggest that SSBs consumption increases the risk of developing breast cancer, particularly in premenopausal women.Impact:Given the consumption of SSBs, of which Mexico is a large consumer, these results can support public policies to discourage the consumption of SSBs.
- 6 February 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Sugar-Sweetened Beverages Consumption and Breast Cancer in Premenopausal and Postmenopausal Women
Background:The consumption of sugar-sweetened beverages (SSB), of which Mexico is a large consumer, has been associated with the risk of breast cancer. We assessed the association between SSBs consumption and breast cancer risk in pre- and postmenopausal women.Methods:We performed a multicenter population-based case–control study in Mexico City, Monterrey, and Veracruz. We recruited 1,000 cases and 1,074 controls; all participants were pre- or postmenopausal women between 35 and 69 years of age. Diet before symptoms onset was assessed using a food frequency questionnaire. We conducted a multivariable-adjusted conditional logistic regression analysis stratified by menopausal status.Results:For premenopausal women, after adjusting for matching characteristics, total energy intake and all potential confounders, the odds of having breast cancer in women who drank one or more SSBs servings per day showed 1.78 times the odds of those who drank one or fewer SSBs servings per month [OR = 1.78; 95% confidence interval (CI), 1.06–3.01]. For postmenopausal women, the corresponding model was not statistically significant (OR = 1.38, 95% CI, 0.84–2.25). We also observed higher consumption of SSBs among pre- than in postmenopausal women (23.3% and 17.4%, respectively among controls in the highest consumption category (≥1 per day).Conclusions:Our results suggest that SSBs consumption increases the risk of developing breast cancer, particularly in premenopausal women.Impact:Given the consumption of SSBs, of which Mexico is a large consumer, these results can support public policies to discourage the consumption of SSBs.